Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma. (Nature communications, 2014)

(untitled) - Müller, J; Krijgsman, O; Tsoi, J; Robert, L; Hugo, W; Song, C; Kong, X; Possik, P; Cornelissen-Steijger, P; Foppen, M; Kemper, K; Goding, C; et al.